From Name

From Email

To Name

To Email

Message

FDA OKs new indication for Esketamine Nasal Spray

from Drug Topics

FDA OKs new indication for Esketamine Nasal Spray Drug Topics The FDA approved esketamine (Spravato; Janssen) CIII nasal spray for the treatment of depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior. READ MORE

more